Fierce Pharma Layoff Tracker 2024. Companies across the industry have contributed to biotech layoffs in early 2024, driven by factors ranging from operational restructuring to strategic pivots and clinical trial failures, with major hubs like california and. On one hand, there’s a group of biotech startups that are thriving, attracting nearly $3 billion in.
Gilead plans to cut 100+ ca roles; Biopharma layoffs rose 57% last year compared to 2022, with 187 industry.